David McMillan

1.1k total citations
15 papers, 547 citations indexed

About

David McMillan is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David McMillan has authored 15 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David McMillan's work include Receptor Mechanisms and Signaling (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Lipid Membrane Structure and Behavior (4 papers). David McMillan is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Lipid Membrane Structure and Behavior (4 papers). David McMillan collaborates with scholars based in United Kingdom, Belgium and United States. David McMillan's co-authors include Tom Ceska, Alastair D. G. Lawson, James P. O’Connell, John Porter, Tim Bourne, Bruce Carrington, David Fox, Rachel E. Davis, Alison Maloney and Manuel Hilbert and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

David McMillan

15 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David McMillan United Kingdom 11 304 99 91 75 74 15 547
Shinya Iida Japan 16 338 1.1× 72 0.7× 32 0.4× 33 0.4× 135 1.8× 47 750
Yong‐Guang Gao China 15 512 1.7× 52 0.5× 27 0.3× 83 1.1× 37 0.5× 35 606
Key-Sun Kim South Korea 12 426 1.4× 139 1.4× 25 0.3× 58 0.8× 154 2.1× 17 717
Jacky Chi Ki Ngo Hong Kong 19 893 2.9× 40 0.4× 47 0.5× 109 1.5× 81 1.1× 45 1.2k
Kyle G. Howell United States 14 339 1.1× 81 0.8× 22 0.2× 41 0.5× 92 1.2× 16 680
Yagmur Muftuoglu United States 9 271 0.9× 197 2.0× 25 0.3× 41 0.5× 112 1.5× 16 509
Tim Gilmartin United States 11 622 2.0× 359 3.6× 61 0.7× 144 1.9× 37 0.5× 11 842
Julian R. Smith United States 11 356 1.2× 175 1.8× 32 0.4× 58 0.8× 97 1.3× 26 694
Carolina Braga Brazil 10 370 1.2× 47 0.5× 100 1.1× 50 0.7× 126 1.7× 16 600
Hiroshi Onogi Japan 14 886 2.9× 71 0.7× 27 0.3× 42 0.6× 122 1.6× 16 1.2k

Countries citing papers authored by David McMillan

Since Specialization
Citations

This map shows the geographic impact of David McMillan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McMillan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McMillan more than expected).

Fields of papers citing papers by David McMillan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McMillan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McMillan. The network helps show where David McMillan may publish in the future.

Co-authorship network of co-authors of David McMillan

This figure shows the co-authorship network connecting the top 25 collaborators of David McMillan. A scholar is included among the top collaborators of David McMillan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McMillan. David McMillan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Davies, Gareth, Paul S. Jones, Lara Kevorkian, et al.. (2023). Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer. mAbs. 15(1). 2289681–2289681. 7 indexed citations
2.
Sarkar, Kaushik, Marta Westwood, Rebecca J. Burnley, et al.. (2022). Modulation of PTH1R signaling by an extracellular binding antibody. Vitamins and hormones. 120. 109–132. 1 indexed citations
3.
Chan‐Tack, Kirk M., Patrick R. Harrington, Suyoung Choi, et al.. (2021). Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Research. 195. 105182–105182. 55 indexed citations
4.
McMillan, David, C. Martinez-Fleites, John Porter, et al.. (2021). Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature Communications. 12(1). 582–582. 63 indexed citations
5.
Lightwood, Daniel, John Porter, David McMillan, et al.. (2021). A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF. Nature Communications. 12(1). 583–583. 22 indexed citations
6.
O’Connell, James P., John Porter, Stephen Rapecki, et al.. (2019). Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature Communications. 10(1). 5795–5795. 81 indexed citations
7.
Morton, Penny E., James A. Levitt, Daniel R. Matthews, et al.. (2019). TNFR1 membrane reorganization promotes distinct modes of TNFα signaling. Science Signaling. 12(592). 25 indexed citations
8.
Sarkar, Kaushik, Marta Westwood, Rebecca J. Burnley, et al.. (2019). Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling. Scientific Reports. 9(1). 14432–14432. 24 indexed citations
9.
Juarez, Juan F. Bada, Juan C. Muñoz–García, Rosana I. Reis, et al.. (2019). Detergent-free extraction of a functional low-expressing GPCR from a human cell line. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(3). 183152–183152. 29 indexed citations
10.
Lovera, Silvia, Gianni De Fabritiis, Sebastian Kelm, et al.. (2019). The Aminotriazole Antagonist Cmpd‐1 Stabilises a Distinct Inactive State of the Adenosine 2A Receptor. Angewandte Chemie International Edition. 58(28). 9399–9403. 5 indexed citations
11.
Lovera, Silvia, Gianni De Fabritiis, Sebastian Kelm, et al.. (2019). The Aminotriazole Antagonist Cmpd‐1 Stabilises a Distinct Inactive State of the Adenosine 2A Receptor. Angewandte Chemie. 131(28). 9499–9503. 1 indexed citations
12.
Adams, Ralph, Rebecca J. Burnley, Chiara R. Valenzano, et al.. (2017). Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling. Scientific Reports. 7(1). 37716–37716. 36 indexed citations
13.
Benoit, Roger, Daniel Frey, Manuel Hilbert, et al.. (2013). Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature. 505(7481). 108–111. 102 indexed citations
14.
Holdsworth, Gill, Patrick M. Slocombe, Carl Doyle, et al.. (2012). Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors. Journal of Biological Chemistry. 287(32). 26464–26477. 78 indexed citations
15.
Meier, Christoph, T.A. Ceska, Carl Doyle, et al.. (2012). Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting. Journal of Structural Biology. 177(2). 329–334. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026